Trials / Completed
CompletedNCT01195363
Quetiapine Sr as Adjunctive Treatment In Mixed States of Bipolar Disorder
A Randomized, Double-Blind, Placebo Controlled Study Of Quetiapine SR (QTP) As Adjunctive Treatment In Mixed States (MS) Of Bipolar Disorder
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- The University of Texas Health Science Center at San Antonio · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
To assess the acute and long-term bimodal efficacy of QTP, as an adjunct to ongoing treatment with lithium (Li) or divalproex (DIV) or lamotrigine (LAM) or any combination of the three thereof, in a group of patients with an index episode of a mixed state in BD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | quetiapine SR | quetiapine SR, dose range 200-600mg, each night QHS for 6mos |
| DRUG | quetiapine sr placebo | quetiapine sr placebo, dose range 200-600mg, each night QHS for 6mos |
Timeline
- Start date
- 2007-04-01
- Primary completion
- 2010-12-01
- Completion
- 2011-06-01
- First posted
- 2010-09-06
- Last updated
- 2017-03-23
- Results posted
- 2015-02-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01195363. Inclusion in this directory is not an endorsement.